BiotechTube
Home/OMEICOS Therapeutics/Robert Fischer
RF

Robert Fischer

CEO, CSO, Co-Founder

OMEICOS Therapeutics

Therapeutic Areas

CardiovascularInflammatory DiseasesMitochondrial Diseases

OMEICOS Therapeutics Pipeline

DrugIndicationPhase
OMT-28Atrial FibrillationPhase 2

Leadership Team at OMEICOS Therapeutics

SR
Simon Russell
CBO (Consultancy)
KU
Karen Uhlmann
Vice President Operations & IP, Co-Founder
View full OMEICOS Therapeutics profile